{
  "id": 194293,
  "name": "QUEST DIAGNOSTICS INCORPORATED",
  "slug": "quest-diagnostics-incorporated",
  "state": "DC",
  "description": "Developing and administering laboratory-based tests.",
  "totalSpending": 1840000,
  "filings": 26,
  "yearlySpending": [
    {
      "year": 2018,
      "income": 60000
    },
    {
      "year": 2019,
      "income": 240000
    },
    {
      "year": 2020,
      "income": 180000
    },
    {
      "year": 2021,
      "income": 240000
    },
    {
      "year": 2022,
      "income": 320000
    },
    {
      "year": 2023,
      "income": 320000
    },
    {
      "year": 2024,
      "income": 240000
    },
    {
      "year": 2025,
      "income": 240000
    }
  ],
  "firms": [
    "RED+BLUE STRATEGIES"
  ],
  "lobbyists": [
    "MELANIE NATHANSON",
    "MEGAN MARSHALL",
    "BENJAMIN KLEIN",
    "KATHRYN WISE"
  ],
  "issues": [
    "HCR",
    "MMM",
    null
  ],
  "sampleDescriptions": [
    "Issues related to innovation, access and affordability of laboratory-based health care modalities in the United States.",
    "Issues related to the promulgation of the Protecting Access to Medicare Act with a focus on ensuring the new reimbursement formulas are in line with beneficiary needs, differentiation in lab-performed tests and general practice guidelines.",
    "Issues related to reform of the Protecting Access to Medicare Act (PAMA) with a focus on ensuring that the data collected to set rates is of the highest integrity.",
    "H.R. 3584 - The Lab Act - focused on issues related to reform of the Protecting Access to Medicare Act (PAMA) with a focus on ensuring that the data collected to set rates is of the highest integrity.",
    "H.R. 3584 - The LAB Act - focused on issues related to reform of the Protecting Access to Medicare Act (PAMA) with a focus on ensuring that the data collected to set rates is of the highest integrity.",
    "H.R. 1865 - Further Consolidated Appropriations Act, 2020 - inclusion of policies regarding data collection from laboratories as dictated by the Protecting Access to Medicare Act (PAMA).\n\nH.R. 3584 - The Lab Act - focused on issues related to reform of the Protecting Access to Medicare Act (PAMA) with a focus on ensuring that the data collected to set rates is of the highest integrity.",
    "H.R. 1865 - Further Consolidated Appropriations Act, 2020 - inclusion of policies regarding data collection from laboratories as dictated by the Protecting Access to Medicare Act (PAMA).\n\nH.R. 3584 - The LAB Act - focused on issues related to reform of the Protecting Access to Medicare Act (PAMA) with a focus on ensuring that the data collected to set rates is of the highest integrity.",
    "Issues related to Administration policies on testing for COVID-19 as well as back to work protocols that include testing. \n\nH.R. 6800 - The HEROES Act - Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19. \n \n\nH.R. 6074 - Implementation -  Coronavirus Preparedness and Response Supplemental Appropriation Act of 2020- Issues related to lab-focused role and response to fighting COVID-19 pandemic. Issues related to the modification of PAMA statute to respond to the health crisis.\n\nH.R. 6201 - Implementation-  Families First Coronavirus Response Act - Issues related to ensuring that the lab-focused capacity and response to fighting the coronavirus are an integral part of the overall federal strategy for keeping the country safe. \n\nH.R. 748 - The CARES Act - Implementation-  Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19.",
    "H.R. 6800 - The HEROES Act - Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19 for Medicare and Medicaid beneficiaries. \n\nH.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriation Act of 2020- Implementation -  Issues related to lab-focused role and response to fighting COVID-19 pandemic. Issues related to the modification of PAMA statute to respond to the health crisis.\n\nH.R. 6201 - Families First Coronavirus Response Act - Implementation -  Issues related to ensuring that the lab-focused capacity and response to fighting the coronavirus are an integral part of the overall federal strategy for keeping the country safe. \n\nH.R. 748 - The CARES Act - Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19.",
    "H.R. 8319 - Continuing Appropriation Act 2021 - Ensuring that \"health extenders\" are addressed. \n\nH.R. 8406 - The HEROES Act (modified) - Issues related to ensuring that individuals have access to accurate testing methods for COVID-19. \n\nSenate HEALS Act - Issues related to ensuring that individuals have access to accurate testing methods for COVID-19.\n\nH.R. 6800 - The HEROES Act - Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19 for Medicare and Medicaid beneficiaries. \n\nH.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriation Act of 2020- Implementation -  Issues related to lab-focused role and response to fighting COVID-19 pandemic. Issues related to the modification of PAMA statute to respond to the health crisis.\n\nH.R. 6201 - Families First Coronavirus Response Act - Implementation -  Issues related to ensuring that the lab-focused capacity and response to fighting the coronavirus are an integral part of the overall federal strategy for keeping the country safe. \n\nH.R. 748 - The CARES Act - Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19.",
    "H.R. 8319 - Continuing Appropriation Act 2021 - Ensuring that \"health extenders\" are addressed. \n\nH.R. 8406 - The HEROES Act (modified) - Issues related to ensuring that individuals have access to accurate testing methods for COVID-19. \n\nSenate HEALS Act - Issues related to ensuring that individuals have access to accurate testing methods for COVID-19.\n\nIssues related to Administration policies on testing for COVID-19 as well as back to work protocols that include testing. \n\nH.R. 6800 - The HEROES Act - Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19. \n \n\nH.R. 6074 - Implementation -  Coronavirus Preparedness and Response Supplemental Appropriation Act of 2020- Issues related to lab-focused role and response to fighting COVID-19 pandemic. Issues related to the modification of PAMA statute to respond to the health crisis.\n\nH.R. 6201 - Implementation-  Families First Coronavirus Response Act - Issues related to ensuring that the lab-focused capacity and response to fighting the coronavirus are an integral part of the overall federal strategy for keeping the country safe. \n\nH.R. 748 - The CARES Act - Implementation-  Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19.",
    "P.L. 116-260/H.R. 133 - Consolidated Appropriations Act of 2021 - Issues related to the fight against COVID-19 including issues of vaccine distribution, testing policies and procedures and support of the nation's health care system,  patients, families and their care providers. \n\nH.R. 8319 - Continuing Appropriation Act 2021 - Ensuring that \"health extenders\" are addressed. \n\nH.R. 8406 - The HEROES Act (modified) - Issues related to ensuring that individuals have access to accurate testing methods for COVID-19. \n\nSenate HEALS Act - Issues related to ensuring that individuals have access to accurate testing methods for COVID-19.\n\nH.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriation Act of 2020- Implementation -  Issues related to lab-focused role and response to fighting COVID-19 pandemic. Issues related to the modification of PAMA statute to respond to the health crisis.\n\nH.R. 6201 - Families First Coronavirus Response Act - Implementation -  Issues related to ensuring that the lab-focused capacity and response to fighting the coronavirus are an integral part of the overall federal strategy for keeping the country safe. \n\nH.R. 748 - The CARES Act - Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19.",
    "P.L. 116-260/H.R. 133 - Consolidated Appropriations Act of 2021 - Issues related to the fight against COVID-19 including issues of vaccine distribution, testing policies and procedures and support of the nation's health care system,  patients, families and their care providers. \n\nH.R. 8319 - Continuing Appropriation Act 2021 - Ensuring that \"health extenders\" are addressed. \n\nH.R. 8406 - The HEROES Act (modified) - Issues related to ensuring that individuals have access to accurate testing methods for COVID-19. \n\nSenate HEALS Act - Issues related to ensuring that individuals have access to accurate testing methods for COVID-19.\n\nIssues related to Administration policies on testing for COVID-19 as well as back to work protocols that include testing. \n\nH.R. 6074 - Implementation -  Coronavirus Preparedness and Response Supplemental Appropriation Act of 2020- Issues related to lab-focused role and response to fighting COVID-19 pandemic. Issues related to the modification of PAMA statute to respond to the health crisis.\n\nH.R. 6201 - Implementation-  Families First Coronavirus Response Act - Issues related to ensuring that the lab-focused capacity and response to fighting the coronavirus are an integral part of the overall federal strategy for keeping the country safe. \n\nH.R. 748 - The CARES Act - Implementation-  Issues related to support for the laboratory and health care sectors writ large to allow for rapid response to the fight against COVID-19.",
    "PL 117-2 - The American Rescue Act - Issues related to testing regimes for COVID-19\n\nPL 116-260 - Implementation of previsions related to clinical laboratories,; No Surprises Act and Transparency issues. \n\nFederal policy and programs related to k-12 schools testing for COVID-19\n\nFederal policy and programs ensuring an equitable pandemic response and recovery\n\nIssues related laboratory data collection and reimbursement under PAMA.",
    "PL 117-2 - The American Rescue Plan Implementation - Issues related to testing regimes for COVID-19\n\nPL 116-260 - Implementation of previsions related to clinical laboratories and Transparency issues. \n\nFederal policy and programs related to k-12 schools testing for COVID-19 through the Medicaid and CHIP programs.\n\nFederal policy and programs ensuring an equitable pandemic response and recovery in the testing sector.\n\nIssues related laboratory data collection and reimbursement under PAMA.",
    "Issues related to the Biden Administration's protocols and work to include testing in the response to combat the COVD-19 virus. \n\nPL 117-2 - The American Rescue Act Implementation - Issues related to testing regimes for COVID-19\n\nPL 116-260 - Implementation of previsions related to clinical laboratories,; No Surprises Act and Transparency issues. \n\nFederal policy and programs related to k-12 schools testing for COVID-19\n\nFederal policy and programs ensuring an equitable pandemic response and recovery\n\nIssues related laboratory data collection and reimbursement under PAMA.",
    "Ongoing issues related to the Biden Administration's protocols and work to include testing in the response to combat the COVD-19 virus.\n\nPL 117-2 - The American Rescue Plan Implementation - Issues related to testing regimes for COVID-19\n\nPL 116-260 - Implementation of previsions related to clinical laboratories and Transparency issues. \n\nFederal policy and programs related to k-12 schools testing for COVID-19 through the Medicaid and CHIP programs.\n\nFederal policy and programs ensuring an equitable pandemic response and recovery in the testing sector.\n\nIssues related laboratory data collection and reimbursement under PAMA.",
    "H.R. 2471 - The Consolidated Appropriations Act of FT 2022 Issues related to protocols and work to include testing in the response to combat the COVD-19 virus and Congressional action to continue to fund such programs. PL 117-2 - The American Rescue Act Implementation - Issues related to testing regimes for COVID-19 PL 116-260 - Implementation of previsions related to clinical laboratories,; No Surprises Act and Transparency issues. Federal policy and programs related to k-12 schools testing for COVID-19 Federal policy and programs ensuring an equitable pandemic response and recovery Issues related laboratory data collection and reimbursement under PAMA.",
    "H.R. 2471 - The Consolidated Appropriations Act of FT 2022 Issues related to protocols and work to include testing in the response to combat the COVD-19 virus and Congressional action to continue to fund such programs. PL 117-2 - The American Rescue Plan Implementation - Issues related to testing regimes for COVID-19 PL 116-260 - Implementation of previsions related to clinical laboratories and Transparency issues. Federal policy and programs related to k-12 schools testing for COVID-19 through the Medicaid and CHIP programs. Federal policy and programs ensuring an equitable pandemic response and recovery in the testing sector. Issues related laboratory data collection and reimbursement under PAMA.",
    "S. 4449 - The Saving Access to Laboratory Services Act of 2022 - Issue related to Medicare reimbursement for laboratory services. PL 117-2 - The American Rescue Act Implementation - Issues related to testing regimes for COVID-19 PL 116-260 - Implementation of previsions related to clinical laboratories,; No Surprises Act and Transparency issues. Federal policy and programs ensuring an equitable pandemic response and recovery"
  ],
  "years": [
    2018,
    2019,
    2020,
    2021,
    2022,
    2023,
    2024,
    2025
  ],
  "growthRate": 300,
  "trajectory": "exploding",
  "yearsActive": 8,
  "avgAnnualSpending": 230000,
  "peakYear": 2022,
  "lobbyistCount": 4,
  "firmCount": 1,
  "issueCount": 2
}